Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Lower Q2 Expenses, Advances Lucid-MS Into Phase 2.
Austin, Texas, United States, 17th August 2026, FinanceWire … Read More The post Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Lower Q2 Expenses, Advances Lucid-MS Into Phase 2 appeared first on FinanceWire - Financial Press Release Distribution, Finance PR.

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Lower Q2 Expenses, Advances Lucid-MS Into Phase 2.
Austin, Texas, United States, 17th August 2026, FinanceWire … Read More The post Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) Reports Lower Q2 Expenses, Advances Lucid-MS Into Phase 2 appeared first on FinanceWire - Financial Press Release Distribution, Finance PR.

Source:https://financewire.com/2026/08/17/quantum-biopharma-nasdaq-qntm-cse-qntm-reports-lower-q2-expenses-advances-lucid-ms-into-phase-2/